Many individuals acquire infections each year, yet few progress to critical illness. The current inability to identify the proportion of individuals who will progress to life-threatening illness is a major impediment to effective management of infectious disease. Using malaria as a model, the aim of the project is to identify and validate a panel of biomarkers in blood that reliably detects individuals at risk of lifethreatening disease.
Information and communication technologies (ICTs) are poised to have increasingly larger roles in health care systems globally and one possible scenario is that Ontario emerges as a leader in providing eHealth innovation and service delivery. Although ICT-based methods of service delivery are well established in particular areas of health care, the potential benefits for hearing health care have not been fully realized due to a number of technological and non-technological barriers. Foremost among them, successful aural rehabilitation requires face-to-face consultations where practitioner
Scisense is a medical device company focused on Micro Sensor technology used to monitor cardio dynamics in animals as small as mice. Scisense's existing production process l-Or building the micro sensor probes is a tedious process that requires a high degree of skilled labour and ultimately results in a low yield of marketable devices. The company's growth is limited by this yield potential.
This project will be focused on the testing of the performance of a new type of parallel RF coil system that allows for significantly higher signal to noise and imaging performance than currently available coil systems (estimated 3 times higher signal to noise and acceleration of imaging times by a factor of 8-16 times). The coil system which will be tested is a breast imaging coil designed for operation with a 3T GE DVMR imaging platform. The coils to be compared are designed with 8 channel, 16 channel and 32 channel coil arrays.
The project aims to enhance design control software that drives an automated specimen processing robotic system. This robotic system automates the processes of biological specimen containers handling and labelling. It is used to increase the productivity of microbiology laboratories and quality of their results. This robotic system controller handles hundreds of specimen containers in a single run. The task requires operating tens of motors simultaneously, which increases the complexity of the controller software significantly.
The wear of polyethylene components in total knee replacements is one of the major factors limiting the longevity and success of knee replacements. The project will use finite element analysis and mathematical wear calculations to model wear in a total knee replacement. The model will then be used to compare the wear rate of conventional polyethylene, normally used in knee replacements to the new highly]cross linked polyethylene which recently became available.
Mespere Lifesciences Inc. (Waterloo, ON) has developed a technology platform based upon near infrared spectroscopy for non-invasive, real time monitoring of the hemodynamics within central venous blood vessels. The project engineer will help in the development of a beta version of a handheld non-invasive central venous pressure monitor. Mespere currently has a working prototype based on a laptop and the new and clear requirements and execution plan for the development of a final commercial product.
This internship will enable a very successful collaboration to continue between Alcohol Countermeasure Systems Corp. and Trent University, associated with designing and constructing a new generation of all‐optical breath alcohol sensors. The high‐sensitivity, highselectivity breathalysers that will emerge from this collaboration are expected to become a valued diagnostic tool within many sectors, from professional to recreational.
In this project, 10 older patients who have uncontrolled diabetes will use wireless technology including a blood glucose monitor and a Blackberry or a Tablet PC to transmit their blood glucose readings from home to two nurses working at a private homecare company. These patients will transmit their blood glucose readings approximately three times a day during two 3]month phases, the total duration of the study period being 6 months. Throughout, patientsf blood glucose levels will be monitored by the two nurses.